

REMAP-CAP Trial Long Term Outcomes
Mar 13, 2024
Dr. Lisa Higgins presents long-term outcomes of REMAP-CAP trial at Critical Care Reviews Meeting 2023. Prof. Christopher Seymour explores 180-day outcomes for pandemic patients. Analysis includes treatments like antivirals, corticosteroids, and anticoagulants. Challenges in post-ICU follow-up and successes of platforms like Remap Cap discussed.
Chapters
Transcript
Episode notes
1 2 3 4 5 6
Introduction
00:00 • 2min
Long-Term Outcomes in ICU Patients from REMAP-CAP Trial
01:59 • 9min
Assessing Patient Health and Disability Levels with Utility Scores and WHODAS 2.0
10:46 • 2min
Analysis of COVID-19 Treatment Domains and Mortality Outcomes
12:41 • 5min
Challenges in Following up Patients after ICU Discharge
17:26 • 7min
Successes and Challenges in Pandemic Response
24:00 • 23min